Sea Limited
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Xiao Dong Li
- Full Time Employees
- 102,700
- Sector
- Retail trade
- Industry
- Internet retail
- Address
- 1 Fusionopolis Place Singapore CE Singapore 138522
- IPO Date
- Oct 20, 2017
- CIK
- 0001703399
- Website
- sea.com
- Similar Companies
- Business
- Sea Limited (NYSE: SE) is a Singapore-based consumer internet company founded in 2009 and headquartered at 1 Fusionopolis Place, Singapore, that operates leading digital platforms across e-commerce, digital financial services, and digital entertainment in Southeast Asia, Latin America, the rest of Asia, and internationally. The company offers Shopee, a mobile-centric e-commerce marketplace connecting individual and household buyers with small and medium-sized businesses, brands, and large retailers through integrated payments, seller services, logistics infrastructure, and digital advertising; Garena, a digital entertainment platform providing access to mobile and PC online games including Arena of Valor, EA Sports FC Online, and Call of Duty: Mobile, alongside eSports operations and in-house game development; and Monee (formerly SeaMoney), a suite of digital financial services encompassing consumer and SME credit, mobile wallets such as ShopeePay, payment processing, buy-now-pay-later under SPayLater, banking, insurtech underwriting via SeaInsure for life and non-life insurance products, and insurance agency services. Sea Limited targets underserved consumers and small businesses to drive technology-enabled growth, with over 67,000 employees supporting operations that generated $16.8 billion in revenue for 2024. Recent developments include the May 2025 rebranding of SeaMoney to Monee with a new digital financial services headquarters in Singapore; additional capital injections totaling $78 million into MariBank Singapore in early 2025, bringing cumulative investment to $488 million since 2021; the April 2025 acquisition and rebranding of SeaBank Philippines to MariBank Philippines, completing its integration under MariBank's group structure; the 2025 launch of Ryt Bank, an AI-powered digital bank in Malaysia via a joint venture with YTL Digital Capital featuring the Ryt AI conversational assistant; and regulatory approvals in Brazil in August 2025 for SCD and SCFI licenses to expand lending operations and replicate its fintech model in Latin America.
Company News
Sea Limited Sponsored ADR (SE) Stock Slides as Market Rises: Facts to Know Before You Trade
Is Trending Stock Sea Limited Sponsored ADR (SE) a Buy Now?
Sea Limited Sponsored ADR $SE Position Lowered by Kapitalo Investimentos Ltda
Equinor's North Sea Oil & Gas Discovery Boosts Oseberg's Resources
Sea Limited Sponsored ADR $SE Stock Bought by Banque Pictet & Cie SA
2 Tech Stocks to Buy Now and Hold for a Decade (Hint: 1 Isn't in the AI Trade)
Sea Limited Sponsored ADR (SE) Outperforms Broader Market: What You Need to Know
Equinor makes North Sea oil discovery
Is It Worth Investing in Sea Limited (SE) Based on Wall Street's Bullish Views?
Equinor makes gas discovery in North Sea
Is Most-Watched Stock Sea Limited Sponsored ADR (SE) Worth Betting on Now?
Sea Limited Sponsored ADR (SE) Outperforms Broader Market: What You Need to Know
Sea (NYSE: SE) insider sells 40,000 shares in preplanned trade
SEA (NYSE:SE) Insider Sells 40,000 Shares of Stock
SEA (NYSE:SE) Insider Yanjun Wang Sells 1,000 Shares of Stock
Apache workers back strike that could disrupt North Sea Forties oil pipeline, union says
Sea Limited: A Buy-The-Dip Case Is Taking Shape
SEA (NYSE:SE) Insider Yanjun Wang Sells 1,000 Shares of Stock
Sea: Scaling Is Evident For Shopee, With Raised Profit Targets
Here Are Thursday’s Top Wall Street Analyst Research Calls: BP, Dollar Tree, Exxon Mobil, Lennar, Occidental Petroleum, Rocket Lab, Teva Pharmaceuticals, United Therapeutics, and More